| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50242-132-10 | 50242-132 | HUMAN PRESCRIPTION DRUG | Herceptin | Trastuzumab | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20190603 | N/A | BLA | BLA103792 | Genentech, Inc. | TRASTUZUMAB | 150 mg/7.4mL | 10 VIAL, SINGLE-DOSE in 1 CARTON (50242-132-10) / 15 mL in 1 VIAL, SINGLE-DOSE |
| 50242-132-01 | 50242-132 | HUMAN PRESCRIPTION DRUG | Herceptin | Trastuzumab | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20170210 | N/A | BLA | BLA103792 | Genentech, Inc. | TRASTUZUMAB | 150 mg/7.4mL | 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-132-01) / 15 mL in 1 VIAL, SINGLE-DOSE |